Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft-Tissue Sarcoma in a National Cohort.

Kim JK, Verma N, McBride S, Riaz N, Boyle JO, Spielsinger D, Sabol C, Waldenberg T, Brinkman T, Alektiar K, Lee NY, Tsai CJ.

Laryngoscope. 2019 Mar 20. doi: 10.1002/lary.27901. [Epub ahead of print]

PMID:
30892716
2.

Immediate Dental Implantation in Oncologic Jaw Reconstruction: Workflow Optimization to Decrease Time to Full Dental Rehabilitation.

Allen RJ Jr, Shenaq DS, Rosen EB, Patel SG, Ganly I, Boyle JO, Nelson JA, Matros E.

Plast Reconstr Surg Glob Open. 2019 Jan 14;7(1):e2100. doi: 10.1097/GOX.0000000000002100. eCollection 2019 Jan.

3.

A Virtual Surgical Planning Algorithm for Delayed Maxillomandibular Reconstruction.

Stranix JT, Stern CS, Rensberger M, Ganly I, Boyle JO, Allen RJ Jr, Disa JJ, Mehrara BJ, Garfein ES, Matros E.

Plast Reconstr Surg. 2019 Apr;143(4):1197-1206. doi: 10.1097/PRS.0000000000005452.

PMID:
30676509
4.

Haemorrhage following transoral robotic surgery.

Hay A, Migliacci J, Karassawa Zanoni D, Boyle JO, Singh B, Wong RJ, Patel SG, Ganly I.

Clin Otolaryngol. 2018 Apr;43(2):638-644. doi: 10.1111/coa.13041. Epub 2017 Dec 26.

5.

Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.

Leeman JE, Li JG, Pei X, Venigalla P, Zumsteg ZS, Katsoulakis E, Lupovitch E, McBride SM, Tsai CJ, Boyle JO, Roman BR, Morris LGT, Dunn LA, Sherman EJ, Lee NY, Riaz N.

JAMA Oncol. 2017 Nov 1;3(11):1487-1494. doi: 10.1001/jamaoncol.2017.0973.

6.

Complications following transoral robotic surgery (TORS): A detailed institutional review of complications.

Hay A, Migliacci J, Karassawa Zanoni D, Boyle JO, Singh B, Wong RJ, Patel SG, Ganly I.

Oral Oncol. 2017 Apr;67:160-166. doi: 10.1016/j.oraloncology.2017.02.022. Epub 2017 Feb 28.

7.

White adipose tissue inflammation and cancer-specific survival in patients with squamous cell carcinoma of the oral tongue.

Iyengar NM, Ghossein RA, Morris LG, Zhou XK, Kochhar A, Morris PG, Pfister DG, Patel SG, Boyle JO, Hudis CA, Dannenberg AJ.

Cancer. 2016 Dec 15;122(24):3794-3802. doi: 10.1002/cncr.30251. Epub 2016 Aug 10.

8.

The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform.

Morris LGT, Chandramohan R, West L, Zehir A, Chakravarty D, Pfister DG, Wong RJ, Lee NY, Sherman EJ, Baxi SS, Ganly I, Singh B, Shah JP, Shaha AR, Boyle JO, Patel SG, Roman BR, Barker CA, McBride SM, Chan TA, Dogan S, Hyman DM, Berger MF, Solit DB, Riaz N, Ho AL.

JAMA Oncol. 2017 Feb 1;3(2):244-255. doi: 10.1001/jamaoncol.2016.1790.

9.

Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.

William WN Jr, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, Tang X, Kim ES, Saintigny P, Blair EA, Meiller T, Gutkind JS, Myers J, El-Naggar A, Lippman SM.

JAMA Oncol. 2016 Feb;2(2):209-16. doi: 10.1001/jamaoncol.2015.4364.

10.

Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongue.

Iyengar NM, Kochhar A, Morris PG, Morris LG, Zhou XK, Ghossein RA, Pino A, Fury MG, Pfister DG, Patel SG, Boyle JO, Hudis CA, Dannenberg AJ.

Cancer. 2014 Apr 1;120(7):983-91. doi: 10.1002/cncr.28532. Epub 2014 Jan 21.

11.

Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma.

Montero PH, Yu C, Palmer FL, Patel PD, Ganly I, Shah JP, Shaha AR, Boyle JO, Kraus DH, Singh B, Wong RJ, Morris LG, Kattan MW, Patel SG.

Cancer. 2014 Jan 15;120(2):214-21. doi: 10.1002/cncr.28407. Epub 2013 Oct 25.

12.

Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.

Gyorki DE, Boyle JO, Ganly I, Morris L, Shaha AR, Singh B, Wong RJ, Shah JP, Busam K, Kraus D, Coit DG, Patel S.

Eur J Surg Oncol. 2014 Mar;40(3):305-10. doi: 10.1016/j.ejso.2013.11.017. Epub 2013 Dec 13.

PMID:
24361245
13.

A novel tumor: specimen index for assessing adequacy of resection in early stage oral tongue cancer.

Montero PH, Palmer FL, Shuman AG, Patel PD, Boyle JO, Kraus DH, Morris LG, Shah JP, Shaha AR, Singh B, Wong RJ, Ganly I, Patel SG.

Oral Oncol. 2014 Mar;50(3):213-20. doi: 10.1016/j.oraloncology.2013.11.009. Epub 2013 Dec 12.

PMID:
24332395
14.

Outcomes of a head and neck cancer screening clinic.

Shuman AG, McKiernan JT, Thomas D, Patel P, Palmer FL, Shaffer BT, Shah JP, Patel SG, Boyle JO.

Oral Oncol. 2013 Dec;49(12):1136-40. doi: 10.1016/j.oraloncology.2013.09.007. Epub 2013 Sep 29.

PMID:
24084407
15.

Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers.

Mohebati A, Milne GL, Zhou XK, Duffield-Lillico AJ, Boyle JO, Knutson A, Bosworth BP, Kingsley PJ, Marnett LJ, Brown PH, Akpa EG, Szabo E, Dannenberg AJ.

Cancer Prev Res (Phila). 2013 Jul;6(7):646-55. doi: 10.1158/1940-6207.CAPR-13-0083. Epub 2013 May 16.

16.

Selective neck dissection in node-positive squamous cell carcinoma of the head and neck.

Givi B, Linkov G, Ganly I, Patel SG, Wong RJ, Singh B, Boyle JO, Shaha AR, Shah JP, Kraus DH.

Otolaryngol Head Neck Surg. 2012 Oct;147(4):707-15. Epub 2012 Apr 18.

17.

Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma.

Saltman BE, Ganly I, Patel SG, Coit DG, Brady MS, Wong RJ, Boyle JO, Singh B, Shaha AR, Shah JP, Kraus DH.

Head Neck. 2010 Dec;32(12):1686-92. doi: 10.1002/hed.21390.

PMID:
20848412
18.

UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.

Judson BL, Miyaki A, Kekatpure VD, Du B, Gilleaudeau P, Sullivan-Whalen M, Mohebati A, Nair S, Boyle JO, Granstein RD, Subbaramaiah K, Krueger JG, Dannenberg AJ.

Cancer Prev Res (Phila). 2010 Sep;3(9):1104-11. doi: 10.1158/1940-6207.CAPR-10-0089. Epub 2010 Jul 19.

19.

Effects of cigarette smoke on the human oral mucosal transcriptome.

Boyle JO, Gümüs ZH, Kacker A, Choksi VL, Bocker JM, Zhou XK, Yantiss RK, Hughes DB, Du B, Judson BL, Subbaramaiah K, Dannenberg AJ.

Cancer Prev Res (Phila). 2010 Mar;3(3):266-78. doi: 10.1158/1940-6207.CAPR-09-0192. Epub 2010 Feb 23.

20.

Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients.

Kekatpure VD, Boyle JO, Zhou XK, Duffield-Lillico AJ, Gross ND, Lee NY, Subbaramaiah K, Morrow JD, Milne G, Lippman SM, Dannenberg AJ.

Cancer Prev Res (Phila). 2009 Nov;2(11):957-65. doi: 10.1158/1940-6207.CAPR-09-0093. Epub 2009 Oct 20.

21.

UVR exposure sensitizes keratinocytes to DNA adduct formation.

Nair S, Kekatpure VD, Judson BL, Rifkind AB, Granstein RD, Boyle JO, Subbaramaiah K, Guttenplan JB, Dannenberg AJ.

Cancer Prev Res (Phila). 2009 Oct;2(10):895-902. doi: 10.1158/1940-6207.CAPR-09-0125. Epub 2009 Sep 29.

22.

Lymph node density is a significant predictor of outcome in patients with oral cancer.

Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, Singh B, Wong RJ, Patel SG.

Cancer. 2009 Dec 15;115(24):5700-10. doi: 10.1002/cncr.24631.

23.

Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway.

Duffield-Lillico AJ, Boyle JO, Zhou XK, Ghosh A, Butala GS, Subbaramaiah K, Newman RA, Morrow JD, Milne GL, Dannenberg AJ.

Cancer Prev Res (Phila). 2009 Apr;2(4):322-9. doi: 10.1158/1940-6207.CAPR-09-0005. Epub 2009 Mar 31.

24.

Effects of tobacco smoke on gene expression and cellular pathways in a cellular model of oral leukoplakia.

Gümüş ZH, Du B, Kacker A, Boyle JO, Bocker JM, Mukherjee P, Subbaramaiah K, Dannenberg AJ, Weinstein H.

Cancer Prev Res (Phila). 2008 Jul;1(2):100-11. doi: 10.1158/1940-6207.CAPR-08-0007. Epub 2008 Mar 31.

25.

Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis.

Estilo CL, O-charoenrat P, Talbot S, Socci ND, Carlson DL, Ghossein R, Williams T, Yonekawa Y, Ramanathan Y, Boyle JO, Kraus DH, Patel S, Shaha AR, Wong RJ, Huryn JM, Shah JP, Singh B.

BMC Cancer. 2009 Jan 12;9:11. doi: 10.1186/1471-2407-9-11.

26.

Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma.

Gross ND, Patel SG, Carvalho AL, Chu PY, Kowalski LP, Boyle JO, Shah JP, Kattan MW.

Head Neck. 2008 Oct;30(10):1352-60. doi: 10.1002/hed.20879.

PMID:
18720518
27.

Pilot randomized phase II study of celecoxib in oral premalignant lesions.

Papadimitrakopoulou VA, William WN Jr, Dannenberg AJ, Lippman SM, Lee JJ, Ondrey FG, Peterson DE, Feng L, Atwell A, El-Naggar AK, Nathan CO, Helman JI, Du B, Yueh B, Boyle JO.

Clin Cancer Res. 2008 Apr 1;14(7):2095-101. doi: 10.1158/1078-0432.CCR-07-4024.

28.

Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma.

Gross ND, Boyle JO, Du B, Kekatpure VD, Lantowski A, Thaler HT, Weksler BB, Subbaramaiah K, Dannenberg AJ.

Clin Cancer Res. 2007 Oct 1;13(19):5910-7.

29.

Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland.

Picon AI, Coit DG, Shaha AR, Brady MS, Boyle JO, Singh BB, Wong RJ, Busam KJ, Shah JP, Kraus DH.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):9001-9009. Epub 2006 May 23.

30.

Outcomes of primary and secondary tracheoesophageal puncture: a 16-year retrospective analysis.

Cheng E, Ho M, Ganz C, Shaha A, Boyle JO, Singh B, Wong RJ, Patel S, Shah J, Branski RC, Kraus DH.

Ear Nose Throat J. 2006 Apr;85(4):262, 264-7.

PMID:
16696362
31.

Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx.

Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle JO, Wong RJ, Shaha AR, Lee N, Shah JP.

Arch Otolaryngol Head Neck Surg. 2006 Jan;132(1):59-66.

PMID:
16415431
32.

Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx.

Lin K, Patel SG, Chu PY, Matsuo JM, Singh B, Wong RJ, Kraus DH, Shaha AR, Shah JP, Boyle JO.

Head Neck. 2005 Dec;27(12):1042-8.

PMID:
16265657
33.

Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Gross ND, Boyle JO, Morrow JD, Williams MK, Moskowitz CS, Subbaramaiah K, Dannenberg AJ, Duffield-Lillico AJ.

Clin Cancer Res. 2005 Aug 15;11(16):6087-93.

34.

Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands.

Moraitis D, Du B, De Lorenzo MS, Boyle JO, Weksler BB, Cohen EG, Carew JF, Altorki NK, Kopelovich L, Subbaramaiah K, Dannenberg AJ.

Cancer Res. 2005 Jan 15;65(2):664-70.

35.

Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population.

Cohen EG, Patel SG, Lin O, Boyle JO, Kraus DH, Singh B, Wong RJ, Shah JP, Shaha AR.

Arch Otolaryngol Head Neck Surg. 2004 Jun;130(6):773-8.

PMID:
15210562
36.

Cyclooxygenase inhibition as a target for prevention of tobacco-related cancers.

Boyle JO.

Clin Cancer Res. 2004 Mar 1;10(5):1557-8. No abstract available.

37.

Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract.

Almahmeed T, Boyle JO, Cohen EG, Carew JF, Du B, Altorki NK, Kopelovich L, Fang JL, Lazarus P, Subbaramaiah K, Dannenberg AJ.

Carcinogenesis. 2004 May;25(5):793-9. Epub 2004 Jan 16. No abstract available.

PMID:
14729581
38.

Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx.

Matsuo JM, Patel SG, Singh B, Wong RJ, Boyle JO, Kraus DH, Shaha AR, Zelefsky MJ, Pfister DG, Shah JP.

Ann Surg. 2003 Sep;238(3):412-21; discussion 421-2.

39.

Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.

Cohen EG, Almahmeed T, Du B, Golijanin D, Boyle JO, Soslow RA, Subbaramaiah K, Dannenberg AJ.

Clin Cancer Res. 2003 Aug 15;9(9):3425-30.

40.

The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue.

Estilo CL, O-Charoenrat P, Ngai I, Patel SG, Reddy PG, Dao S, Shaha AR, Kraus DH, Boyle JO, Wong RJ, Pfister DG, Huryn JM, Zlotolow IM, Shah JP, Singh B.

Clin Cancer Res. 2003 Jun;9(6):2300-6.

41.

Prospective functional voice assessment in patients undergoing thyroid surgery.

Stojadinovic A, Shaha AR, Orlikoff RF, Nissan A, Kornak MF, Singh B, Boyle JO, Shah JP, Brennan MF, Kraus DH.

Ann Surg. 2002 Dec;236(6):823-32.

42.

Improved outcomes in patients with osteogenic sarcoma of the head and neck.

Patel SG, Meyers P, Huvos AG, Wolden S, Singh B, Shaha AR, Boyle JO, Pfister D, Shah JP, Kraus DH.

Cancer. 2002 Oct 1;95(7):1495-503.

43.

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer.

Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO.

Head Neck. 2002 Aug;24(8):792-9. Review.

PMID:
12203806
44.

Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

Dannenberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K.

Lancet Oncol. 2001 Sep;2(9):544-51. Review.

PMID:
11905709
45.

Primary mucosal malignant melanoma of the head and neck.

Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, Boyle JO, Huvos AG, Busam K, Shah JP.

Head Neck. 2002 Mar;24(3):247-57.

PMID:
11891956
46.

Sentinel lymph node biopsy for cutaneous head and neck melanomas.

Patel SG, Coit DG, Shaha AR, Brady MS, Boyle JO, Singh B, Shah JP, Kraus DH.

Arch Otolaryngol Head Neck Surg. 2002 Mar;128(3):285-91.

PMID:
11886345
47.

Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract.

Dannenberg AJ, Altorki NK, Boyle JO, Lin DT, Subbaramaiah K.

Ann N Y Acad Sci. 2001 Dec;952:109-15. Review.

PMID:
11795429
48.

Retinoid mechanisms and cyclins.

Boyle JO.

Curr Oncol Rep. 2001 Jul;3(4):301-5. Review.

PMID:
11389813
49.

Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.

Boyle JO, Lonardo F, Chang JH, Klimstra D, Rusch V, Dmitrovsky E.

Clin Cancer Res. 2001 Feb;7(2):259-66.

50.

Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer.

Mestre JR, Chan G, Zhang F, Yang EK, Sacks PG, Boyle JO, Shah JP, Edelstein D, Subbaramaiah K, Dannenberg AJ.

Ann N Y Acad Sci. 1999;889:62-71.

PMID:
10668483

Supplemental Content

Loading ...
Support Center